Trial Profile

Nuwiq for Perioperative Management of Patients with Haemophilia a on Emicizumab Regular Prophylaxis Study (NuPOWER)

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Simoctocog alfa (Primary)
Indications Haemophilia A
Focus Therapeutic Use
Acronyms NuPOWER
Sponsors Octapharma

Most Recent Events

24 Jan 2024 Planned initiation date changed from 1 Oct 2023 to 1 Feb 2024.
03 Jul 2023 Status changed from planning to not yet recruiting.
13 Dec 2022 According to trial design presented at 64th American Society of Hematology Annual Meeting and Exposition, this study start is planned for Q4, 2022

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com